Theme: “To share knowledge and expertise on prevention, diagnosis and treatment of the most common diseases in travelers and possible vaccination approache

Global Vaccines Congress 2016
Past Report of Vaccines Asia Pacific-2016

Global Vaccines Congress 2016

Conference series LLC invites all the participants from all over the world to attend “World Congress on Vaccines & Therapeutics: Travel Medicine For Infectious Diseases” which will be held during December 01-02, 2016 NSan Antonio, USA, which includes Prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions. The Theme of the conference is "To share knowledge and expertise on prevention, diagnosis and treatment of the most common diseases in travelers and possible vaccination approaches".

Global Vaccines Congress 2016 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. There will be opportunities for those selected to present at the meeting to also publish a manuscripts and abstracts from their Travel Medicine and Vaccines or its sister publication Immunome Research. Conference series LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Track: 1 Infectious Diseases Types

The Diseases caused by germs and which may infect any part of the body are called Infectious Diseases. They can spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.

With the burgeoning response and grand success of Conference series LLC" takes the pride of announcing the grand commencement of International Conference on Travel Medicine & Vaccines scheduled during December  01-02 in San Antonio, USA.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; Annual Conference on  HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; Vaccines conferences, June 16-18, 2016, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; HIV Vaccines (X8), USA; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA.

Track: 2 Ebola, Arboviral diseases and Haemorrhagic Fever

Nine of the people contracted the disease outside the US and travelled into the country, either as regular airline passengers or as medical evacuees; of those nine, two died. Two people have contracted Ebola in the United States; both were nurses who treated an Ebola patient; both have recovered.Arbovirus is a term used to refer to a group of viruses that are transmitted by arthropod vectors. The word arbovirus is an acronym (ARthropod-BOrne virus).Symptoms of arbovirus infection generally occur 3–15 days after exposure to the virus and last 3 or 4 days. The most common clinical features of infection are fever, headache, and malaise, but encephalitis and hemorrhagic fever may also occur.The word tibovirus (TIck-BOrne virus) is sometimes used to describe viruses transmitted by ticks, a superorder within the arthropods.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines conferences, June 16-18, 2016, Rome, Italy ; annual  Conference on  HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA;  Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA;  HIV Vaccines (X8), USA; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA.

Track: 3  Business People Investment Meet

Entrepreneur is the organize of starting a business, typically a start-up company offering an innovative product, process or service. The entrepreneur perceives an promotion and often exhibits biases in taking the decision to exploit the opportunity. The exploitation of entrepreneurial  a chance for promotion includes design actions  develop a business plan, acquire the human, financial other required resources, and  be responsible for its success or failure. Entrepreneurship may operate within entrepreneurship ecosystem which includes government programs and services that promotes entrepreneurs, entrepreneurship resource In recent years, "entrepreneurship" has been extended from its origins in for-profit businesses to include social entrepreneurship the concept of the political entrepreneur.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

4th HIV/AIDS, STDs, & STIs Conference, November 30-December 02, 2015, USA; 2nd Infectious Diseases Conference, August 25-27, 2016, USA; 2nd Influenza Conference, September 12-14, 2016, Germany; Infection Prevention and Control Conference, Aug 1-2, 2016, Germany; Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA;  World STI & HIV 2015 Congress, Australia; 19th Annual United States Conference on AIDS, USA; 10th International Workshop on HIV Transmission – Principles of Intervention, USA; 5th Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice, Netherlands; 18th Bangkok International Symposium on HIV Medicine, Thailand

Track: 4 Immunization for Emerging and Communicable Diseases

Immunization is one of the most successful and cost-effective health interventions, preventing millions of deaths every year. From infants to seniors, immunization protects against diseases such as diphtheria, measles, pertussis, pneumonia, polio, rotavirus, rubella and tetanus. The benefits of immunization are increasingly being extended to adolescents and adults, providing protection against life-threatening diseases such as influenza, meningitis, and cancers. A communicable disease is one that is spread from one person to another through a variety of ways that include: contact with blood and bodily fluids; breathing in an airborne virus; or by being bitten by an insect.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; Vaccines conferences, June 16-18, 2016, Rome, Italy; 15th Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA;  Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 18th Bangkok International Symposium on HIV Medicine, Thailand; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA.

Track: 5 Global policy/Regulations for Disease prevention and control

To prevent or reduce the burden of infectious diseases of public health importance. There is reduced incidence of infectious diseases of public health importance. There is reduced morbidity and mortality associated with infectious diseases of public health importance. There is increased public capacity to prevent and control infectious diseases. There is increased capacity on the part of all hospitals, long-term care homes (LTCHs), and other settings with risk of infections to prevent and control infectious diseases.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; Vaccines conferences, June 16-18, 2016, Rome, Italy; 15th Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA;  Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 18th Bangkok International Symposium on HIV Medicine, Thailand; HIV Persistence: HIV Vaccines (X8), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA

Track: 6   Global Trends in Emerging Infectious Diseases

An Infectious Disease whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance and public health issues due to unhygienic conditions.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

15th Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA; Vaccines conferences, June 16-18, 2016, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA;  HIV Vaccines (X8), USA; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA.

Track: 7 Animal and Tick-borne Infections

Tick-borne diseases, which afflict humans and other animals, are caused by infectious agents transmitted by tick bites. Tick-borne illnesses are caused by infection with a variety of pathogens, including rickettsia and other types of bacteria, viruses, and protozoa. Because individual ticks can harbour more than one disease-causing agent, patients can be infected with more than one pathogen at the same time, compounding the difficulty in diagnosis and treatment. Currently (2015), there are 16 known tick-borne diseases of humans (four discovered since 2013). As the incidence of tick-borne illnesses increases and the geographic areas in which they are found expand, it becomes increasingly important that health workers be able to distinguish the diverse, and often overlapping, clinical presentations of these diseases.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

15th Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA; Vaccines conferences, June 16-18, 2016, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; IV Persistence: Pathogenesis and Eradication, USA; American Conference for the Treatment of HIV, USA; 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, USA; 14th European Meeting on HIV & Hepatitis Treatment Strategies & Antiviral Drug Resistance- Treatment Strategies & Antiviral Drug Resistance, Italy.

Track: 8 Vaccines Against infectious & Non Infections diseases

Infection is the invasion of an organism's body tissues by disease-causing agents, their multiplication, and the reaction of host tissues to these organisms and the toxins they produce. Infectious disease, also known as transmissible disease or communicable disease, is illness resulting from an infection. using their immune system. Mammalian hosts react to infections with an innate response, often involving inflammation, followed by an adaptive response.Among the vast varieties of microorganisms, relatively few cause disease in otherwise healthy individuals. Infectious disease results from the interplay between those few pathogens and the defenses of the hosts they infect. The appearance and severity of disease resulting from any pathogen, depends upon the ability of that pathogen to damage the host as well as the ability of the host to resist the pathogen.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

4th HIV/AIDS, STDs, & STIs Conference, November 30-December 02, 2015, USA; 2nd Infectious Diseases Conference, August 25-27, 2016, USA; 2nd Influenza Conference, September 12-14, 2016, Germany; Infection Prevention and Control Conference, Aug 1-2, 2016, Germany; Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA;  World STI & HIV 2015 Congress, Australia; 19th Annual United States Conference on AIDS, USA; 10th International Workshop on HIV Transmission – Principles of Intervention, USA; 5th Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice, Netherlands; 18th Bangkok International Symposium on HIV Medicine, Thailand

Track: 9 Allergies and skin diseases - Vaccinations

Skin problems are among the most frequent medical problems in returned travellers. The largest case series of dermatologic problems in returned travellers from the Geo Sentinel Surveillance Network showed that cutaneous larva migrans, insect bites, and bacterial infections were the most frequent skin problems in ill travellers who sought medical care, making up 30% of the 4,742 diagnoses In another review of 165 travellers who returned to France with skin problems, cellulitis, scabies, and pyoderma led the list of skin conditions. These data are biased in that they do not include skin problems that were diagnosed and, in many cases, easily managed during travel or that were self-limited.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

15th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; Vaccines conferences, June 16-18, 2016, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA;  HIV Vaccines (X8), USA; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA.

Track: 10 Malaria sickness in and Treatment

Malaria is caused by the protozoan parasite Plasmodium. Human malaria is caused by four different species of Plasmodium: P. falciparum, P. malaria, P. ovale and P. vivax. Humans occasionally become infected with Plasmodium species that normally infect animals, such as P. knowlesi. As yet, there are no reports of human-mosquitohuman transmission of such “zoonotic” forms of malaria. The malaria parasite is transmitted by female Anopheles mosquitoes, which bite mainly between dusk and dawn. Malaria is an acute febrile illness with incubation period of 7 days or longer. Thus, a febrile illness developing less than 1 week after the first possible exposure is not malaria.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; Vaccines conferences, June 16-18, 2016, Rome, Italy; 15th Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA;  Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 18th Bangkok International Symposium on HIV Medicine, Thailand; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA.

Track: 11 Diarrhea and other Gastrointestinal Disorders

sometimes tourist diarrhoea or traveller’s dysentery, is a stomach and intestinal infection, and the most common illness affecting travellers. It is defined as three or more unformed stools passed by a traveller within a 24-hour period. It is commonly accompanied by abdominal cramps, nausea, and bloating. The diagnosis does not imply causative organism, but enter toxigenic Escherichia coli (ETEC) is the most common pathogen Bacteria are responsible for roughly 80% of cases; most of the rest are caused by viruses and protozoans. Although most travellers with TD recover within a few days with little or no treatment, symptoms can sometimes be severe enough to require medical intervention. In those who are immunocompromised or otherwise prone to serious infections, TD is a significant concern and occasionally even life-threatening.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

2nd Influenza Conference, September 12-14, 2016, Germany; Infection Prevention and Control Conference, Aug 1-2, 2016, Germany; Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA;  World STI & HIV 2015 Congress, Australia; 19th Annual United States Conference on AIDS, USA; 10th International Workshop on HIV Transmission – Principles of Intervention, USA; 5th Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice, Netherlands; 18th Bangkok International Symposium on HIV Medicine, Thailand.

Track: 12 Tuberculosis

Tuberculosis is a bacterial infection caused by a bacterium called Mycobacterium tuberculosis which spread through the lymph nodes and bloodstream to any organ in your body. It is most commonly found in the lungs which attack the lungs and it can also attack any part of the body such as the kidney, spine, and brain.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; Vaccines conferences, June 16-18, 2016, Rome, Italy; 15th Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA;  Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA;18th Bangkok International Symposium on HIV Medicine, Thailand; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA

Track: 13 Rubella Vaccines

Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

The Universe of Prefilled Syringes & Injection Devices Vienna, Australia Vaccines conferences, June 16-18, 2016, Rome, Italy; Annual Conference on  HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA;  Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA;  HIV Vaccines (X8), USA; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA.

Track: 14  Global Market on Infectious Diseases

Global Market Reports of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

15th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; Vaccines conferences, June 16-18, 2016, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA;  HIV Vaccines (X8), USA; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA.

Track: 15 Causes and Symptoms of Infectious Diseases

Infectious Diseases can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to a number of infectious diseases include fever, diarrhoea, fatigue and muscle aches.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

2nd Influenza Conference, September 12-14, 2016, Germany; Infection Prevention and Control Conference, Aug 1-2, 2016, Germany; Annual Conference on  HIV Vaccines, December 08-09, 2016 Philadelphia, USA;  World STI & HIV 2015 Congress, Australia; 19th Annual United States Conference on AIDS, USA; 10th International Workshop on HIV Transmission – Principles of Intervention, USA; 5th Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice, Netherlands; 18th Bangkok International Symposium on HIV Medicine, Thailand.

 

Conference Series LLC Conferences invites all the participants from all over the world to attend “International Conference on Vaccines, Therapeutics &Travel Medicine For Infectious Diseases” during December 01-02, 2016 in San Antonio, USA. which includes explicit Keynote presentations, plenary talks from highly distinguished scientific staff, Poster presentations from talented student communities from Universities and Research labs and Exhibitions from Industries and companies in the vaccine and pharmaceutical sectors.

With the burgeoning response and grand success of Conferenceseries LLC "5th Asia Pacific Global Summit and Expo on Vaccines & Vaccination" held on July 27-28, 2015 in Brisbane, Australia,  This will be the latest in the OMICS International annual vaccine meeting series with 500+ Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas & establish business and research collaborations. Opportunities are there for the reseachers present at the meeting to publish their manuscripts/full-length papers based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research. OMICS International organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ upcoming and previous symposiums and workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about Vaccinology/Immunology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology/Vaccine community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Immunology/Vaccinology are hallmarks of this conference.

Target Audience:

  • Vaccinology/Immunology Students, Scientists
  • Vaccinology/Immunology Researchers
  • Vaccinology/Immunology Faculty
  • Medical Colleges
  • Vaccinology/Immunology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Machinery Manufacturing Companies

 

The "International Conference on Vaccines & Therapeutics, Travel Medicine For Infectious Diseases" to be held at San Antonio, USA during December 01-02, 2016 hosted by Conference series LLC Conferences through the theme "To share knowledge and expertise on prevention, diagnosis and treatment of the most common diseases in travelers and possible vaccination approaches", conference will explore the advances in Vaccines and vaccination. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world. OMICS International Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members and Organizes 300+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies.

Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. Travel Medicine 2016 amasses all the extroverts under one roof of current advances.

For more details please visit- http://childrenvaccines.conferenceseries.com/

   Vaccinology is a major field in eradication of diseases. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and vaccinology as they relate to immunization.

Why San Antonio? 

      Travel Medicine conference durling December  01-02 ,2016  held in USA. From that four are from San Antonio officially the City of San Antonio, is the seventh most populated city in the United States of America and the second most populated city in the state of Texas, with a population of 1,409,019. an Antonio has a diversified economy with about a $96.8 billion metropolitan Gross Domestic Product. This ranks the city 4th among Texas metropolitan areas and 38th in the United States. San Antonio's economy is focused primarily within military, health care, government civil service, financial services, oil and gas and tourism sectors. Within the past twenty years, San Antonio has become a significant location for American-based call centers and has added a significant manufacturing sector centered around automobiles. The city is home to one of the largest concentrations of military bases in the United States, and has become known as "Military City, USA." The city is home to several active military installations: Lackland Air Force Base, Brooke Army Medical Center, Randolph Air Force Base, and Fort Sam Houston. The defense industry in San Antonio employs over 89,000 and provides a $5.25 billion impact to the city's economy

San Antonio officially the City of San Antonio, is the seventh most populated city in the United States of America and the second most populated city in the state of Texas, with a population of 1,409,019. an Antonio has a diversified economy with about a $96.8 billion metropolitan Gross Domestic Product. This ranks the city 4th among Texas metropolitan areas and 38th in the United States. San Antonio's economy is focused primarily within military, health care, government civil service, financial services, oil and gas and tourism sectors. Within the past twenty years, San Antonio has become a significant location for American-based call centers and has added a significant manufacturing sector centered around automobiles. The city is home to one of the largest concentrations of military bases in the United States, and has become known as "Military City, USA." The city is home to several active military installations: Lackland Air Force Base, Brooke Army Medical Center, Randolph Air Force Base, and Fort Sam Houston. The defense industry in San Antonio employs over 89,000 and provides a $5.25 billion impact to the city's economy

 

Conference Highlights: 

  1. Travel Medicine and Infectious Diseases- Etiology and Epidemiology
  2. Immunization for Emerging and Communicable Diseases
  3. Drugs and Vaccines for Travel related Diseases
  4. Medicine for Travelers with Chronic Diseases and Pre-existing diseases
  5. Sports, Aviation and Maritime medicine
  6. Travel Medicine and Care in Pregnancy and Infancy
  7. Animal and Tick-borne Infections
  8. Allergies and skin diseases in Travelers- Vaccinations
  9. Malaria sickness in Travelers and Treatment
  10. Traveler’s Diarrhea and other Gastrointestinal Disorders
  11. Ebola, Arboviral diseases and Hemorrhagic Fever in Travelers
  12. Climate Change and Travelers Health – Early and Late Effects
  13. Travel and Environments- Geographical and Regional perspectives
  14. Health Considerations for Adventure Travel
  15. Practical clinical issues for Travel and Tropical Medicine
  16. Emerging Issues and Future developments in Travel medicine
  17. Global policy/Regulations for Disease prevention and control
  18. Travel safety and Security- Guidelines and Standards

Why to attend???

Travel Medicine 2016 could be an event that brings along a novel and International mixture of giant and medium Vaccinology innovation and incipient trends in vaccines and vaccination, leading universities and vaccinology, vaccination research analysis establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Vaccinology research are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

vaccines@conferenceseries.net

Major Vaccines Associations in & around Seattle.

·     Vaccine research Association

·     USA vaccination association

·     USA medical association

·     USA Children welfare association

·     Association of Travel vaccination

Major Vaccines Associations Globally

·     International Society of Travel Medicine

·     The International Society of Neuroimmunology

·     The International Union of Immunological Societies

·     The Society for Travel Immunology

·     The Society for Leukocyte Biology

·     Transplantation Society

·     British Society for Immunology

·     Cell Death Society

·     European Federation of Immunological Societies

·     European Society of Gene Therapy

·     Federation of African Immunological Societies

·     Federation of American Societies for Experimental Biology

·     Federation of Clinical Immunology Societies

·     Immune Deficiency Foundation

·     Infectious Diseases Society of America

Target Audience:

Travel Medicine 2016 Targets, CEO’s, Directors, Scientists, Professors, Students of all Biotech & Pharma companies, Universities and colleges globally

Vaccines sales in global leader companies 2012(1st quarter):

·     Pfizer 2.2 B $

·     Sanofi 1.7 B $

·     Merck & Co 1.8 B $

·     GSK 2.5 B $

·     Novartis 0.44 B $

·     EBS 0.88 B $

 

 

Companies Associated with Vaccines

·     CareDx

·     Atara

·     Biotherapeutics

·     Benitec Limited

·     InterMune

·     Biotron Limited

·     BioDiem

·     Antisense Therapeutics Limited      

·     GlaxoSmithKline USA Pty Ltd

·     Bionomics

·     USAn Pharmaceutical Industries (API)  

·     BioPharmica Limited

Market Analysis of Vaccines

Tripled in value from USD 5B in 2000 to almost USD 24 B in 2013, Global market projected to rise to USD 100 B by 2025. More than 120 new products in the development pipeline. 60 are of importance for developing countries. UNICEF had a market of 1,03 B$ in 2011, PAHO had 400 million dollars in 2011 and total UN market of 340 million dollars in 2002, 1,430 billion dollars in 2011.

 

Overall Statasticks

 

Vaccines Asia Pacific-2015

 Sensing the raising importance of Vaccines, Conference series LLC International hosted the 5th Asiapacific Global Summit and Expo on Vaccines & Vaccination” (Vaccines Asiapacific-2015), scheduled from July 27-29, 2015 in Brisbane, Australia with a theme “Vaccine Research: From Bench to Bedside”.  Benevolent response and active participation was received from the Editorial Board Members of Conference Series LLC Journals as well as from the Vaccines project managers, Vaccinologists, Immunologists, Vaccine researchers, scientists, doctors, students and leaders from the fields of Vaccines and Vaccination, Immunology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Technologies for the Design, Discovery, formulation and administration of vaccines.
  • Developing Next-Gen Conjugate Vaccines.
  • New trends in carbohydrate-based vaccines.
  • Vaccines for Pregnant Women.
  • Recent advances in animal vaccination
  • Adjuvants for human vaccines—current status, problems and future prospects.
  • Current developments in bacterial conjugate vaccines potency.
  • Recent trends in attenuated vaccines.
  • Advancements in vaccine development
  • Vaccination and quality of life
  • Protein subunits- vaccination.
  • Toxoid vaccines and its importance
  • Geriatric Immunization
  • Vaccines under research and development, major diseases
  • Innovative development of vaccines

The conference was embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Dr. Nikolai Petrovsky, Flinders University, Australia

Dr. Roy Hall, The University of Queensland, Australia

Dr. Jan Fohlman, Växjö and Uppsala University, Sweden

Dr. Istvan Toth, The University of Queensland, Australia

Young Researchers:

Towards the development of oral vaccine delivery systems for lipid core peptide-based vaccines using novel multi-layer engineered nanoliposomes against Group A streptococcus

Nirmal Marasini, The University of Queensland, Australia

Title: A Protective Immune Response Using Asymmetric Multi-Epitope Self-Adjuvanting lipopeptide Vaccine Model

Sharareh Eskandari, The University of Queensland, Australia

Title: Binding and immune modulation properties of mannosylated lipo-peptide vaccines

Bita Sedaghat, The University of Queensland, Australia

Title: Liposomes as a Delivery Platform of Vaccines Against Group A Streptoccocus

Khairunnisa Abdul Ghaffar, University of Queensland, Australia

            ConferenceSeries LLC offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced  in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Vaccines Asiapacific-2015, is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza," 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination" to be held during October 17-19, 2016 Kuala Lumpur, Malaysia.

Keynote Forum

Tracks

Posters&Accepted Abstracts

 For More details: http://vaccines.global-summit.com/asia-pacific/2015/

Vaccines 2014 report

The 4th International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held in September 24-26, 2014 Valencia, Spain. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2014 from OMICS International. Also, the conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:

Overview

http://www.conferenceseries.com/immunology-conferences.php

• Vaccines and the Basic Immune System

• New Approaches for B and T Cells

• Cellular and Molecular-Based Vaccines

• Vaccines Against Infectious Diseases

• Manufacturing, Production and Development of Vaccines

• Regulatory and Ethical Issues of Vaccines and Public Acceptance

• Current Issues on Clinical Evaluation and Field Trials of Vaccines

• Modern Technologies in Vaccine Discovery and Development

• Age-Specific Immune Response to Vaccination

• Novel Delivery technologies in Vaccines and many more...

The response to 4th International Conference on Vaccines & Vaccination was huge and was attended by about 550 attendees representing 55 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included

Jeffrey B Ulmer, Novartis Vaccines USA

Ray Spier, Former President, International Society for Vaccines, UK

Michael G Hanna, CEO, Vaccinogen, Inc., USA and many more...

All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2014.

All accepted abstracts have been indexed in OMICS International -Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.

Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

Sponsors and exhibitors

Sanofi Pasteur SA

U.S. Headquarters, Discovery Drive, Swiftwater, PA 18370

Vaccinogen Inc.,

5300 West view Dr # 406, Frederick, MD 21703, United States

Cellular Technology Limited (CTL)

North & South America

CTL Headquarters, 20521 Chagrin Blvd., Shaker Heights, OH 44122-5350 USA,

Gen Phar

600 Seacoast Pkwy # 100,

Mt Pleasant, SC 29464, United States

Vaccines-2013 Report

OMICS International, the global leader in organizing annual “International conferences and Exhibitions on Vaccines and Vaccinations” The Annual Vaccines Conferences provides high-quality, current reports of scientific progress and best practices featured in both invited presentations and submitted oral abstracts and posters. The Global Vaccines Conferences and Expos organized by OMICS International, bring together the diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. By drawing upon an global audience of CEOs, CSOs, scientists and researchers, healthcare professionals and trainees, veterinarians, vaccine manufacturers, and public health officials, the conference is designed to encourage the exchange of ideas across a broad range of disciplines.

 Highlights of Annual Global Vaccines Conferences-OMICS International

 • Keynote forum

• Exhibitions

• Company Presentations

• Speaker Forum

• Workshops and Symposia’s

• B2B Meetings

• One to One meeting

• Special Session for Students

• Scientific writing

• Journal review

• Grant writing

• Strategies for building a scientific career

• Scientific careers outside of research

• Company Promotions

• Young Research Forum

• Best Poster Awards

• Certification by the “International Organizing committee” and many more... 

Vaccines-2012 Report

The 2nd International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held in August 20-22, 2012 in Hilton Chicago/Northbook, USA. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2012 from OMICS International. Vaccines 2012 hosted 300+ attendees representing 55 countries from different corners of the world. The conference was carried out through various sessions, in which the discussions were held on the following

 Scientific tracks:

• Vaccines and the Basic Immune System

• New Approaches for B and T Cells

• Cellular and Molecular-Based Vaccines

• Vaccines Against Infectious Diseases

• Manufacturing, Production and Development of Vaccines

• Regulatory and Ethical Issues of Vaccines and Public Acceptance

• Current Issues on Clinical Evaluation and Field Trials of Vaccines

• Modern Technologies in Vaccine Discovery and Development

• Age-Specific Immune Response to Vaccination and many more...

 Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

The response to 2nd International Conference on Vaccines & Vaccination was huge and was attended by about 300 attendies representing 25 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included

 De-Chu Christopher Vaxin Inc., USA

John Dong GenPhar, USA

Donald E. Greydanus Western Michigan University School of Medicine, USA

Eli Young OpSaniTx, USA

Takashi Kei Kishimoto Selecta Biosciences, USA

Daniel H Zimmerman CEL-SCI Corporation, USA

Gerardo Kaplan FDA, USA

Kei Amemiya U.S. Army Medical Research Institute of Infectious Diseases, USA

Haval Shirwan University of Louisville, USA and many more.

All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2012.All accepted abstracts have been indexed in OMICS International- Journal of Vaccines & Vaccination as a specialissue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.

Vaccines-2011 Conference Report

The International Conference and Exhibition on Vaccines & Vaccination (Vaccines-2011) was held on November

22-24, 2011 in Philadelphia Airport Marriott Hotel, USA. This successful conference organized by OMICS Group brought together Medical Specialists, Researchers and Vaccine Developers who were delighted with the many speeches, presentations, and discussions, which demonstrated the determination to innovate and improve knowledge on Vaccines.Vaccines-2011, helped to open new ideas, advanced technologies, innovative approaches towards Vaccines. Several speakers from almost 30 countries have participated in this conference which was carried out through several sessions with the theme “Current Strategies in Vaccination”.

Conference highlighted the following topics:

• Vaccines and the basic immune system

• New approaches for B and T cells

• Cellular and molecular-based vaccines

• Vaccines against infectious diseases

• Therapeutic vaccine manufacturing, production and development

• Logical and ethical issues and vaccines

• Experimental and clinical evaluation of therapeutic vaccines

• Basic Vaccinology and modern vaccine discovery technologies and many more...

The Luxurious accommodation during the conference also created a relaxed and informal atmosphere with

aright setting for highly interactive sessions where the speakers shared the knowledge on current issues and

strategies of Vaccines and Vaccination.

We take an immense pleasure in thanking our Keynote Speakers:

Gary Alan Flory Virginia Department of Environmental Quality, USA

Gregory J. Tobin Biological Mimetics, Inc. (BMI), USA

Kei Amemiya US Army Medical Research Institute, USA

Edmund J. Gosselin Albany Medical College, USA

Mansour Mohamadzadeh University of Florida, USA and many more...

Vaccines 2011 hosted 200+ attendees representing 30 countries from different corners of the world.

 Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

We are grateful to all speakers, scientific societies, governmental and non-governmental institutions, Professors, scientists, representatives of patient groups from throughout the world for their commitment and the support. We would like to thank our organizing committee members for providing advice on the agenda, and in supporting the conference. We are grateful to NIH, GSK, Sanofi Pasture, and other sponsors for their invaluable support for the success of the event. Journal of Vaccines & Vaccination and Journal of Clinical & Cellular Immunology have published all papers presented at this meeting as a special issue. With the overwhelming response and suggestions and feedbacks from our previous attendees. OMICS International is organizing its Global Vaccines conferences in major countries across the globe: We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Vaccines-2012.

 


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 01-02, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2
Poster Opportunity Available

Media Partners

Conferenceseries Destinations